Kimberly C. Wiegand

4.0k total citations
13 papers, 1.2k citations indexed

About

Kimberly C. Wiegand is a scholar working on Molecular Biology, Reproductive Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kimberly C. Wiegand has authored 13 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Reproductive Medicine and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kimberly C. Wiegand's work include Chromatin Remodeling and Cancer (5 papers), Ovarian cancer diagnosis and treatment (5 papers) and Sarcoma Diagnosis and Treatment (2 papers). Kimberly C. Wiegand is often cited by papers focused on Chromatin Remodeling and Cancer (5 papers), Ovarian cancer diagnosis and treatment (5 papers) and Sarcoma Diagnosis and Treatment (2 papers). Kimberly C. Wiegand collaborates with scholars based in Canada, United States and Ireland. Kimberly C. Wiegand's co-authors include David G. Huntsman, C. Blake Gilks, Steve E. Kalloger, Winnie Yang, Sohrab P. Shah, Janine Senz, Leah Prentice, Jessica N. McAlpine, Christine Chow and Nataliya Melnyk and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and American Journal Of Pathology.

In The Last Decade

Kimberly C. Wiegand

13 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kimberly C. Wiegand Canada 9 606 569 346 301 288 13 1.2k
Michael Churchman United Kingdom 21 473 0.8× 371 0.7× 136 0.4× 247 0.8× 409 1.4× 45 1.1k
Andrew Berchuck United States 10 560 0.9× 268 0.5× 157 0.5× 249 0.8× 375 1.3× 11 1.1k
T Kita Japan 5 310 0.5× 576 1.0× 237 0.7× 135 0.4× 179 0.6× 14 871
Johanna Tapper Finland 14 701 1.2× 267 0.5× 85 0.2× 246 0.8× 339 1.2× 22 1.4k
Vinod Vathipadiekal United States 16 709 1.2× 389 0.7× 69 0.2× 165 0.5× 286 1.0× 23 1.2k
Arisa Ueki Japan 19 386 0.6× 160 0.3× 140 0.4× 191 0.6× 213 0.7× 66 870
Fumio Kataoka Japan 16 268 0.4× 312 0.5× 255 0.7× 65 0.2× 248 0.9× 54 814
Keisuke Kurose Japan 14 634 1.0× 128 0.2× 111 0.3× 191 0.6× 312 1.1× 30 1.0k
Matthieu Le Gallo France 14 490 0.8× 136 0.2× 193 0.6× 92 0.3× 290 1.0× 23 1.0k
Liancheng Zhu China 20 657 1.1× 222 0.4× 87 0.3× 48 0.2× 226 0.8× 72 1.1k

Countries citing papers authored by Kimberly C. Wiegand

Since Specialization
Citations

This map shows the geographic impact of Kimberly C. Wiegand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberly C. Wiegand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberly C. Wiegand more than expected).

Fields of papers citing papers by Kimberly C. Wiegand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimberly C. Wiegand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberly C. Wiegand. The network helps show where Kimberly C. Wiegand may publish in the future.

Co-authorship network of co-authors of Kimberly C. Wiegand

This figure shows the co-authorship network connecting the top 25 collaborators of Kimberly C. Wiegand. A scholar is included among the top collaborators of Kimberly C. Wiegand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimberly C. Wiegand. Kimberly C. Wiegand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
Wiegand, Kimberly C., Keiyan Sy, Steve E. Kalloger, et al.. (2014). ARID1A/BAF250a as a prognostic marker for gastric carcinoma: a study of 2 cohorts. Human Pathology. 45(6). 1258–1268. 37 indexed citations
3.
Anglesio, Michael S., Kimberly C. Wiegand, Nataliya Melnyk, et al.. (2013). Correction: Type-Specific Cell Line Models for Type-Specific Ovarian Cancer Research. PLoS ONE. 8(10). 31 indexed citations
4.
Lichner, Zsuzsanna, Andreas Scorilas, Nicole M. White, et al.. (2013). The Chromatin Remodeling Gene ARID1A Is a New Prognostic Marker in Clear Cell Renal Cell Carcinoma. American Journal Of Pathology. 182(4). 1163–1170. 57 indexed citations
5.
McConechy, Melissa K., Jiarui Ding, Janine Senz, et al.. (2013). Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles. Modern Pathology. 27(1). 128–134. 186 indexed citations
6.
Anglesio, Michael S., Kimberly C. Wiegand, Nataliya Melnyk, et al.. (2013). Type-Specific Cell Line Models for Type-Specific Ovarian Cancer Research. PLoS ONE. 8(9). e72162–e72162. 197 indexed citations
7.
McConechy, Melissa K., Jiarui Ding, Maggie C.U. Cheang, et al.. (2012). Use of mutation profiles to refine the classification of endometrial carcinomas. The Journal of Pathology. 228(1). 20–30. 246 indexed citations
8.
Atkinson, Carter T., Kimberly C. Wiegand, Dennis Triglia, & Susan I. Jarvi. (2012). REVERSION TO VIRULENCE AND EFFICACY OF AN ATTENUATED CANARYPOX VACCINE IN HAWAI‘I ‘AMAKIHI (HEMIGNATHUS VIRENS). Journal of Zoo and Wildlife Medicine. 43(4). 808–819. 7 indexed citations
9.
Wiegand, Kimberly C., Anna F. Lee, Osama M. Al‐Agha, et al.. (2011). Loss of BAF250a (ARID1A) is frequent in high‐grade endometrial carcinomas. The Journal of Pathology. 224(3). 328–333. 180 indexed citations
10.
Jarvi, Susan I., et al.. (2011). Major histocompatibility complex class II gene diversity and tolerance to avian malaria in Hawaiian honeycreepers (Drepanidinae) (99.15). The Journal of Immunology. 186(1_Supplement). 99.15–99.15. 1 indexed citations
11.
Atkinson, Carter T., Kimberly C. Wiegand, Dennis Triglia, & Susan I. Jarvi. (2010). Efficacy of a commercial cararypox vaccine for protecting Hawai`i `Amakihi from field isolates of avipoxvirus.. CTIT technical reports series. 1 indexed citations
12.
McAlpine, Jessica N., Kimberly C. Wiegand, M.W. Miller, et al.. (2010). HER2 Overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy. Gynecologic Oncology. 116(3). 593–594. 4 indexed citations
13.
McAlpine, Jessica N., Kimberly C. Wiegand, Russell Vang, et al.. (2009). HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy. BMC Cancer. 9(1). 151 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Churchman Breakdown of academic impact, for papers by Andrew Berchuck Breakdown of academic impact, for papers by T Kita Breakdown of academic impact, for papers by Johanna Tapper Breakdown of academic impact, for papers by Vinod Vathipadiekal Breakdown of academic impact, for papers by Arisa Ueki Breakdown of academic impact, for papers by Fumio Kataoka Breakdown of academic impact, for papers by Keisuke Kurose Breakdown of academic impact, for papers by Matthieu Le Gallo Breakdown of academic impact, for papers by Liancheng Zhu
Rankless by CCL
2026